Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04821817Completed
Randomised, double-blind trial of rocuronium in strabismus (2 arms), sponsored by Tanta University. Primary endpoint: Duration of globe akinesia. Started Apr 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04821817.